Levels of blood and urine chemicals associated with longer duration of having arsenicosis in Bangladesh

International Journal of Environmental Health Research

Volumn 15, Issue 4, 2005, Pages 289-301

  Khan, M M H ^a,e   Hossain, M K ^b   Kobayashi, Kota ^a   Sakauchi, Fumio ^a   Yamashita, Toshiharu ^a   Ahmed, M Feroze ^c   Hossain, M Delwar ^c   Quamruzzaman, Q ^d   Mori, Mitsuru ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Department of Chemistry Shahajalal University of Science and Technology   (Bangladesh)

^c BANGLADESH UNIVERSITY OF ENGINEERING AND TECHNOLOGY   (Bangladesh)

^d Dhaka Community Hospital   (Bangladesh)

^e SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arsenic; Arsenicosis; Bangladesh; Blood; Cross sectional study; Skin lesion; Urine

Indexed keywords

ARSENIC; BLOOD; POLLUTION EXPOSURE;

ADULT; ARSENIC POISONING; ARTICLE; BANGLADESH; BLOOD ANALYSIS; CHRONIC BRONCHITIS; CONJUNCTIVITIS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; PUBLIC HEALTH; SCREENING; URINALYSIS;

ADULT; ARSENIC POISONING; BANGLADESH; BLOOD GLUCOSE; FEMALE; HEMATOLOGIC TESTS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; SERUM ALBUMIN; TIME FACTORS; TRIGLYCERIDES; URINALYSIS;

ASIA; BANGLADESH; EASTERN HEMISPHERE; EURASIA; SOUTH ASIA; WORLD;

EID: 21844478766     PISSN: 09603123     EISSN: None     Source Type: Journal    
DOI: 10.1080/09603120500155831     Document Type: Article

References (56)

1. Abernathy CO, Liu Y-P, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M. 1999. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 107:593-597.
2. Andrew AS, Karagas MR, Hamilton JW. 2003. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer 104:263-268.
3. BBS. 1994. Analytical report of population census 1991. Vol. 1. Dhaka: Ministry of Planning, Statistics Wing, Bangladesh Bureau of Statistics.
4. BGS and DPHE. 2001. Arsenic concentration of groundwater in Bangladesh. In Volume 2: Final report (D.G. Kinniburgh, P.L. Smedley, eds). Keyworth: British Geological Survey (BGS) Report WC/00/19, BGS.
5. Boquist L, Boquist S, Ericsson I. 1998. Structural β-cell changes and transient hyperglycemia in mice treated with compounds inducing inhibited citric acid cycle enzyme activity. Diabetes 37:89-98.
6. Centeno JA, Mullick FG, Martinez L, Page NP, Gibb H, Longfellow D, Thompson C, Ladich ER. 2002. Pathology related to chronic arsenic exposure. Environ Health Perspect 110(suppl):S883-886.
7. Chen C-J, Chen CW, Wu M-M, Huo T-L. 1992. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888-892.
8. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. 2004. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 25:1779-1786.
9. Chen Y, Ahsan H. 2004. Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health 94:741-744.
10. Chien C-W, Chiang M-C, Ho I-C, Lee T-C. 2004. Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT keratinocytes in nude mice. Environ Health Perspect 112:1704-1710.
11. Chiou H-Y, Chiou S-T, Hsu Y-H, Chou Y-L, Tseng C-H, Wei M-L, Chen C-J. 2001. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153:411-418.
12. Chiou H-Y, Hsueh Y-M, Liaw K-F, Horng S-F, Chiang M-H, Pu Y-S, Lin JS-N, Huang C-H, Chen C-J. 1995. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55:1296-1300.
13. Chiou PW-S, Chen K-L, Yu B. 1997. Effects of roxarsone on performance, toxicity, tissue accumulation and residue of eggs and excreta in laying hens. J Sci Food Agric 74:229-236.
14. Chiu HF, Ho SC, Wang LY, Wu TN, Yang CY. 2004 Does arsenic exposure increase the risk for liver cancer? J Toxicol Environ Health A 67:1491-1500.
15. Chowdhury AMR. 2004. Arsenic crisis in Bangladesh. Sci Am 291:86-91.
16. Cui X, Li S, Shraim A, Kobayashi Y, Hayakawa T, Kanno S, Yamamoto M, Hirano S. 2004. Subchronic exposure to arsenic through drinking water alters expression of cancer-related genes in rat liver. Toxicol Pathol 32:64-72.
17. Dong Z. 2002. The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ Health Perspect 110(suppl):S757-759.
18. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. 2000. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiol 11:673-679.
19. Frumkin H, Thun MJ. 2001. Arsenic. CA. Cancer J Clin 51:254-262.
20. Germolec DR, Spalding J, Yu H-S, Chen GS, Simeonova PP, Humble MC, Bruccoleri A, Boorman GA, Foley JF, Yoshida T, Luster MI. 1998. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am J Pathol 153:1775-1785.
21. Guha Mazumder DN. 2003. Chronic arsenicosis toxicity: clinical features, epidemiology, and treatment: experience in West Bengal. J Environ Sci Health A 38:141-163.
22. Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, Smith AH. 1998. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 27:871-877.
23. Haque R, Guha Mazumder DN, Samanta S, Ghosh N, Kalman D, Smith MM, Mitra S, Santra A, Lahiri S, Das S, De BK, Smith AH. 2003. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiol 14:174-182.
24. Hindmarsh JT. 2000. Arsenic, its clinical and environmental significance. J Trace Elem Exp Med 13:165-172.
25. Hopenhayn-Rich C, Biggs ML, Smith AH. 1998. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol 27:561-569.
26. Hsueh Y-M, Cheng G-S, Wu M-M, Yu H-S, Kuo T-L, Chen C-J. 1995. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer 71:109-114.
27. Josephson J. 2001. Arsenic and endocrines: new study suggests disruption. Environ Health Perspect 109:A132-133.
28. Kadono T, Inaoka T, Murayama N, Ushijima K, Nagano M, Nakamura S, Watanabe C, Tamaki K, Ohtsuka R. 2002. Skin manifestations of arsenicosis in two villages in Bangladesh. Int J Dermatol 41:841-846.
29. Kaltreider RC, Davis AM, Lariviere JP, Hamilton JW. 2001. Arsenic alters the function of the Glucocorticoid receptor as a transcription factor. Environ Health Perspect 109:245-251.
30. Khan AW, Ahmed SA. 2002. Arsenic in drinking water: health effects and management. Training manual. In: Rashid H-A, editor. Research studies on health impact of arsenic exposure. pp. 330-365. Dhaka: Bangladesh Medical Research Council (BMRC).
31. Khan MMH, Sakauchi F, Sonoda T, Washio M, Mori M. 2003. Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: evidence from a review of the literature. Asian Pac J Cancer Prev 4:7-14.
32. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J. 1999. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 107:705-710.
33. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM, Tai TY. 1994. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 139:484-492.
34. Luster MI, Simeonova PP. 2004. Arsenic and urinary bladder cell proliferation. Toxicol Appl Pharmacol 198:419-423.
35. Mandal BK, Suzuki KT. 2002. Arsenic round the world: a review. Talanta 58:201-235.
36. Milton AH. 2003. Health effects of arsenic: toxicity, clinical manifestation and health management. In: Ahmed MF, editor. Arsenic contamination: Bangladesh perspective. Dhaka: ITN-Bangladesh, Centre for water supply and waste management, BUET. pp 281-297.
37. Milton AH, Hasan Z, Rahman A, Rahman M. 2003. Non-cancer effects of chronic arsenicosis in Bangladesh: preliminary results. J Environ Sci Health A 38:301-305.
38. Milton AH, Hasan Z, Shahidullah SM, Sharmin S, Jakariya MD, Rahman M, Dear K, Smith W. 2004. Association between nutritional status and arsenicosis due to chronic exposure in Bangladesh. Int J Environ Health Res 14:99-108.
39. Mitra AK, Bose BK, Kabir H, Das BK, Hussain M. 2002. Arsenic-related health problems among hospital patients in southern Bangladesh. J Health Popul Nutr 20:198-204.
40. nd, Ferreccio C, Rey OA, Waldman FM. 2002. Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst 94:1688-1696.
41. Mure K, Uddin AN, Lopez LC, Styblo M, Rossman TG. 2003. Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations. Environ Mol Mutagen 41:322-331.
42. Quamruzzaman Q. 2002. Patient identification and management in 7 Upzilas. Dhaka: UNICEF.
43. Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, Paul K, Lodh D, Biswas BK, Chanda CR, Basu GK, Saha KC, Roy S, Das R, Palit SK, Quamruzzaman Q, Chakraboti D. 2001. Chronic arsenic toxicity in Bangladesh and West Bengal, India-a review and commentary. Clin Toxicol 39:683-700.
44. Rahman M, Tondel M, Ahmad SA, Axelson O. 1998. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol 148:198-203.
45. Roy P, Saha A. 2002. Metabolism and toxicity of arsenic: a human carcinogen. Curr Sci 82:38-45.
46. Saha KC. 2003. Diagnosis of arsenicosis. J Environ Sci Health A 38:255-272.
47. Smith AH, Goycolea M, Haque R, Biggs ML. 1998. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 147:660-669.
48. Smith AH, Lingas EO, Rahman M. 2000. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ 78:1093-1103.
49. Spallholz JE, Boylan LM, Rahman MM. 2004. Environmental hypothesis: is poor dietary selenium intake an underlying factor for arsenicosis and cancer in Bangladesh and West Bengal, India? Sci Total Environ 323:21-32.
50. Sun GF. 2004. Arsenic contamination and arsenicosis in China. Toxicol Appl Pharmacol 198:268-271.
51. Tseng CH, Tai TY, Chong CK, Tseng CP, Lai MS, Lin BJ, Chiou HY, Hsueh YM, Hsu KH, Chen CJ. 2000. Long term arsenic exposure and incidence of non-insulin diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 108:847-851.
52. Wang C-H, Jeng J-S, Yip P-K, Chen C-L, Hsu L-I, Hsueh Y-M, Chiou H-Y, Wu M-M, Chen C-J. 2002. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105:1804-1809.
53. Wu M-M, Chiou H-Y, Wang T-W, Hsueh Y-M, Wang I-H, Chen C-J, Lee T-C. 2001. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of Northeastern Taiwan. Environ Health Perspect 109:1011-1017.
54. Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130:1123-1132.
55. Yoshida T, Yamauchi H, Sun GF. 2004. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol Appl Pharmacol 198:243-252.
56. Yu RC, Hsu K-H, Chen C-J, Froines JR. 2000. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 9:1259-1262.